Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke
about
Macrophage-mediated cholesterol handling in atherosclerosisTo Use or Not to Use Metformin in Cerebral Ischemia: A Review of the Application of Metformin in Stroke RodentsAn Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke.Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4.Glucose-Dependent Insulinotropic Polypeptide Ameliorates Mild Traumatic Brain Injury-Induced Cognitive and Sensorimotor Deficits and Neuroinflammation in Rats.Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4.Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art.Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke.A Review on the Phytochemistry, Pharmacology, Pharmacokinetics and Toxicology of Geniposide, a Natural Product.Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor.Mechanisms of foam cell formation in atherosclerosis.The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway.
P2860
Q26780405-6AFA1AC9-10FF-43E5-961A-0471FA425857Q33787067-6D7C2526-8794-4977-AD88-A4678B5252B8Q35919831-16A88D49-21A0-491F-A930-1061AC14F5E5Q36905790-EFFF7397-19A2-4293-85CC-F90543DCDD5FQ37424923-14FC7DCF-EC23-4FBE-93C1-0AEC7363F21CQ37473323-98110CB2-0D2D-4B99-A574-B513762207A6Q37714724-3FAE6FD1-581D-4273-9633-12B5E9FA04FFQ38730622-80BE37CB-9C15-4B1D-9FF0-4DC38B7CED73Q46289886-4CDC8507-E075-4253-9681-A46527097CF6Q48926149-853D0F87-41C2-40AD-AC95-712CCC32DBE8Q52759762-F95594A5-32C9-4205-81F1-E5B03905049CQ55163277-B9E74559-C416-4D99-A25C-88C325CAD3FF
P2860
Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Glucagon-like receptor 1 agoni ...... es for the treatment of stroke
@ast
Glucagon-like receptor 1 agoni ...... es for the treatment of stroke
@en
Glucagon-like receptor 1 agoni ...... es for the treatment of stroke
@nl
type
label
Glucagon-like receptor 1 agoni ...... es for the treatment of stroke
@ast
Glucagon-like receptor 1 agoni ...... es for the treatment of stroke
@en
Glucagon-like receptor 1 agoni ...... es for the treatment of stroke
@nl
prefLabel
Glucagon-like receptor 1 agoni ...... es for the treatment of stroke
@ast
Glucagon-like receptor 1 agoni ...... es for the treatment of stroke
@en
Glucagon-like receptor 1 agoni ...... es for the treatment of stroke
@nl
P2093
P2860
P50
P356
P1476
Glucagon-like receptor 1 agoni ...... es for the treatment of stroke
@en
P2093
David Nathanson
Thomas Klein
Thomas Nyström
P2860
P304
P356
10.1038/JCBFM.2015.17
P407
P577
2015-05-01T00:00:00Z